Aspen Pharmacare Holdings Limited Stock Other OTC
Stocks
APNHY
US04530Y1064
Pharmaceuticals
OTC Markets Traded| Market Cap | 65.55B 4.09B 3.51B 3.28B 3B 5.63B 392B 5.71B 38.75B 15.11B 197B 15.36B 15.03B 651B | P/E 2026 * |
15x | P/E 2027 * | 12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 78.43B 4.9B 4.19B 3.92B 3.59B 6.74B 468B 6.83B 46.36B 18.08B 235B 18.38B 17.98B 778B | EV / Sales 2026 * |
2.08x | EV / Sales 2027 * | 1.64x |
| Free-Float |
59.64% | Yield 2026 * |
1.8% | Yield 2027 * | 1.7% |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | +3.81% |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 1996-12-31 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 2008-12-31 |
| Chief Operating Officer | 63 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Saad
BRD | Director/Board Member | 62 | 1998-12-31 |
| Director/Board Member | 65 | 1998-12-31 | |
Kuseni Dlamini
CHM | Chairman | 58 | 2015-12-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.81% | +15.11% | - | - | 4.09B | |
| -0.08% | -1.43% | +15.99% | +67.26% | 47.71B | |
| -3.21% | +1.37% | +52.36% | +125.75% | 40.3B | |
| -0.40% | -1.23% | -10.08% | +16.08% | 12.09B | |
| +1.11% | -1.34% | +13.61% | +71.49% | 11.68B | |
| 0.00% | +0.58% | +30.65% | +148.80% | 9.19B | |
| -0.39% | -0.92% | +19.81% | +39.54% | 7.57B | |
| -1.35% | +0.74% | +47.03% | -11.93% | 7.24B | |
| -0.64% | -0.02% | +19.42% | +199.06% | 6.84B | |
| -5.36% | -6.36% | -36.28% | +18.28% | 5.42B | |
| Average | -0.65% | -1.11% | +16.95% | +74.93% | 16.45B | |
| Weighted average by Cap. | -1.02% | -0.57% | +24.44% | +83.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.62B 2.35B 2.01B 1.88B 1.72B 3.23B 225B 3.28B 22.24B 8.67B 113B 8.82B 8.63B 373B | 38.86B 2.43B 2.08B 1.94B 1.78B 3.34B 232B 3.38B 22.97B 8.96B 117B 9.11B 8.91B 386B |
| Net income | 4.8B 300M 257M 240M 220M 412M 28.66B 418M 2.84B 1.11B 14.4B 1.12B 1.1B 47.61B | 5B 312M 267M 250M 229M 429M 29.84B 435M 2.95B 1.15B 14.99B 1.17B 1.15B 49.57B |
| Net Debt | 12.88B 804M 689M 644M 590M 1.11B 76.91B 1.12B 7.61B 2.97B 38.64B 3.02B 2.95B 128B | -1.74B -108M -92.79M -86.82M -79.47M -149M -10.36B -151M -1.03B -400M -5.21B -407M -398M -17.22B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
